Springer Healthcare IME: Podcast to Practice - Podcast

エピソード

Key CGM Updates and Highlights from the EASD 2024 Conference | S3E3
3 10月· Springer Healthcare IME: Podcast to Practice
Dr. Jennifer Green discusses breaking news and clinical implications of data presented at EASD 2024 on CGM technology use in type 2 diabetes.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
The effects of time on blood-based biomarkers | S1E7
15 8月· Springer Healthcare IME: Podcast to Practice
Petrice Cogswell summarizes research looking at temporal modelling of blood-based biomarkers and when to use them to predict brain amyloid deposition.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
エピソードを見逃しましたか？

フィードを更新するにはここをクリックしてください。
Is it too soon to use blood-based biomarkers for AD in primary care? | S1E6
5 8月· Springer Healthcare IME: Podcast to Practice
Michelle Mielke discusses the current status for blood-based biomarker use in primary care in light of research presented at AAIC24.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Discussing the potential for blood based biomarker use | S1E5
5 8月· Springer Healthcare IME: Podcast to Practice
Rik Ossenkoppele discusses the latest research presented on blood-based biomarkers, including their accuracy for diagnosing Alzheimer’s disease and when best to use them.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Advances in therapies that work across multiple disease disciplines | S5E4
18 7月· Springer Healthcare IME: Podcast to Practice
Explore advances in therapies available for CKD in T2D and the clinical evidence and guidelines supporting their use with Professor Nilolaus Marx
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Improving integration of guidelines for CKD in T2D in clinical practice | S5E3
18 7月· Springer Healthcare IME: Podcast to Practice
Learn about evidence-based guidelines for management of CKD in T2D and how these can be integrated into clinical practice with Professor David Cherney
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Improving recognition, diagnosis and classification of CKD in T2D | S5E2
18 7月· Springer Healthcare IME: Podcast to Practice
Listen to Professor Pinar Topsever discuss the risk factors for CKD in T2D, how to recognise and diagnose CKD in patients with T2D, and the barriers to recognition and diagnosis in practice.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Overview of the diabetes-cardio-kidney spectrum and importance of proactive management | S5E1
18 7月· Springer Healthcare IME: Podcast to Practice
Listen to Professor Tina Vilsbøll provide an overview of diabetic kidney disease (DKD) and the diabetes-cardio-kidney spectrum, as she discusses the importance of proactive identification and management.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Key CGM Updates and Highlights from the ADA 2024 Conference | S3E2
4 7月· Springer Healthcare IME: Podcast to Practice
Dr. Eugene Wright, Jr. discusses breaking news and clinical implications of data presented at the ADA 2024 conference on CGM technology.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Optimal approaches for resectable ALK-driven NSCLC | S4E3
25 6月· Springer Healthcare IME: Podcast to Practice
Dr. Solange Peters shares invaluable insights into the management of ALK-positive NSCLC with a special focus on adjuvant therapy.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Navigating NSCLC: Merging molecular insights and targeted therapy | S4E2
25 6月· Springer Healthcare IME: Podcast to Practice
Dr. Lizza Hendriks explores a complex case involving a 40-year-old male with ALK-rearranged non-small cell lung cancer (NSCLC).
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Targeted therapy for ALK-positive NSCLC: A practical case study | S4E1
25 6月· Springer Healthcare IME: Podcast to Practice
Dr. Jamie L. Schneider, delves into the practical considerations for targeted therapy in ALK-rearranged non-small cell lung cancer (NSCLC) through an engaging patient case commentary.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Coping with PBC: Treatment challenges and QoL insights | S2E3
25 6月· Springer Healthcare IME: Podcast to Practice
Kris Kowdley meets with patient Sabrina Reeser as they discuss the patient experience of treatment for PBC, including treatment challenges, variability in doctor-patient communication and involvement in clinical trials.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Key CGM Updates and Highlights from the ATTD 2024 Conference | S3E1
17 4月· Springer Healthcare IME: Podcast to Practice
Dr. Rozalina McCoy discusses breaking news and clinical implications of data presented at the ATTD 2024 conference on CGM technology.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Walking the path of PBC: Navigating symptoms and QoL | S2E2
9 4月· Springer Healthcare IME: Podcast to Practice
David Jones meets with patient and patient advocate Mo Christie as they discuss the patient experience for PBC, including the burden of the disease and its impact on quality of life, with special reference to the common, and commonly misunderstood symptom, itch.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
The evolving landscape of PBC: New therapies and future directions | S2E1
9 4月· Springer Healthcare IME: Podcast to Practice
Kris Kowdley and David Jones share their insights on the evolving landscape of Primary Biliary Cholangitis (PBC), including new and upcoming therapy options, and how these may change practice for the disease
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Breakfast bites: Highlights from CONy 2024 | S1E4
25 3月· Springer Healthcare IME: Podcast to Practice
Professor Zvezdan Pirtošek comments on a session about whether lecanemab treatment should extend beyond 18 months.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Breakfast bites: Highlights from CONy 2024 | S1E3
25 3月· Springer Healthcare IME: Podcast to Practice
Professor Lea Grinberg explains research on how Alzheimer's Disease is linked to sleep disturbance, and whether interventions for bad sleep can stop tiredness as a risk factor.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Breakfast bites: Highlights from ADPD 2024™ | S1E2
13 3月· Springer Healthcare IME: Podcast to Practice
Professor Oskar Hansson summarises sessions from ADPD 2024™ on anti-amyloid immunotherapies
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Breakfast bites: Highlights from ADPD 2024™ | S1E1
12 3月· Springer Healthcare IME: Podcast to Practice
Professor Charlotte Teunissen summarises research presented at ADPD 2024™ about alzheimer's biomarkers, a novel assay for multiphosphorylated tau and the impact of confounding factors.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く

エピソード

Key CGM Updates and Highlights from the EASD 2024 Conference | S3E3

The effects of time on blood-based biomarkers | S1E7

Is it too soon to use blood-based biomarkers for AD in primary care? | S1E6

Discussing the potential for blood based biomarker use | S1E5

Advances in therapies that work across multiple disease disciplines | S5E4

Improving integration of guidelines for CKD in T2D in clinical practice | S5E3

Improving recognition, diagnosis and classification of CKD in T2D | S5E2

Overview of the diabetes-cardio-kidney spectrum and importance of proactive management | S5E1

Key CGM Updates and Highlights from the ADA 2024 Conference | S3E2

Optimal approaches for resectable ALK-driven NSCLC | S4E3

Navigating NSCLC: Merging molecular insights and targeted therapy | S4E2

Targeted therapy for ALK-positive NSCLC: A practical case study | S4E1

Coping with PBC: Treatment challenges and QoL insights | S2E3

Key CGM Updates and Highlights from the ATTD 2024 Conference | S3E1

Walking the path of PBC: Navigating symptoms and QoL | S2E2

The evolving landscape of PBC: New therapies and future directions | S2E1

Breakfast bites: Highlights from CONy 2024 | S1E4

Breakfast bites: Highlights from CONy 2024 | S1E3

Breakfast bites: Highlights from ADPD 2024™ | S1E2

Breakfast bites: Highlights from ADPD 2024™ | S1E1